Gray HJ - Search Results

1

Common polymorphism in interleukin 6 influences survival of women with ovarian and peritoneal carcinoma.

Garg R, Wollan M, Galic V, Garcia R, Goff BA, Gray HJ, Swisher E. Garg R, et al. Among authors: gray hj. Gynecol Oncol. 2006 Dec;103(3):793-6. doi: 10.1016/j.ygyno.2006.08.043. Epub 2006 Oct 4. Gynecol Oncol. 2006. PMID: 17023036 Free PMC article.

2

Glassy cell carcinoma of the cervix revisited.

Gray HJ, Garcia R, Tamimi HK, Koh WJ, Goff BA, Greer BE, Paley PJ. Gray HJ, et al. Gynecol Oncol. 2002 May;85(2):274-7. doi: 10.1006/gyno.2001.6523. Gynecol Oncol. 2002. PMID: 11972387

3

Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer.

Goodell V, Salazar LG, Urban N, Drescher CW, Gray H, Swensen RE, McIntosh MW, Disis ML. Goodell V, et al. J Clin Oncol. 2006 Feb 10;24(5):762-8. doi: 10.1200/JCO.2005.03.2813. Epub 2006 Jan 3. J Clin Oncol. 2006. PMID: 16391298

4

Common polymorphisms in TP53 and MDM2 and the relationship to TP53 mutations and clinical outcomes in women with ovarian and peritoneal carcinomas.

Galic V, Willner J, Wollan M, Garg R, Garcia R, Goff BA, Gray HJ, Swisher EM. Galic V, et al. Among authors: gray hj. Genes Chromosomes Cancer. 2007 Mar;46(3):239-47. doi: 10.1002/gcc.20407. Genes Chromosomes Cancer. 2007. PMID: 17171684

5

An evaluation of cervical cancer in women age sixty and over.

Fox KV, Shah CA, Swisher EM, Garcia RL, Mandel LS, Gray HJ, Swensen RE, Goff BA. Fox KV, et al. Among authors: gray hj. Gynecol Oncol. 2008 Apr;109(1):53-8. doi: 10.1016/j.ygyno.2007.12.028. Epub 2008 Feb 5. Gynecol Oncol. 2008. PMID: 18255127

6

Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer.

Shah CA, Allison KH, Garcia RL, Gray HJ, Goff BA, Swisher EM. Shah CA, et al. Among authors: gray hj. Gynecol Oncol. 2008 May;109(2):215-9. doi: 10.1016/j.ygyno.2008.01.010. Epub 2008 Mar 7. Gynecol Oncol. 2008. PMID: 18314181

7

Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.

Gray HJ, Shah CA, Swensen RE, Tamimi HK, Goff BA. Gray HJ, et al. Gynecol Oncol. 2010 Mar;116(3):340-4. doi: 10.1016/j.ygyno.2009.10.054. Epub 2009 Nov 17. Gynecol Oncol. 2010. PMID: 19922987

8

Ovarian cancer in the elderly: outcomes with neoadjuvant chemotherapy or primary cytoreduction.

McLean KA, Shah CA, Thompson SA, Gray HJ, Swensen RE, Goff BA. McLean KA, et al. Among authors: gray hj. Gynecol Oncol. 2010 Jul;118(1):43-6. doi: 10.1016/j.ygyno.2010.03.002. Epub 2010 Apr 27. Gynecol Oncol. 2010. PMID: 20398918

9

The abandoned radical hysterectomy for cervical cancer: clinical predictors and outcomes.

Gray HJ, Seifert E, Sal Y Rosas VG, Nicandri KF, Koh WJ, Goff BA. Gray HJ, et al. Obstet Gynecol Int. 2010;2010:743794. doi: 10.1155/2010/743794. Epub 2010 Apr 28. Obstet Gynecol Int. 2010. PMID: 20454444 Free PMC article.

10

FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence.

Press JZ, Allison KH, Garcia R, Everett EN, Pizer E, Swensen RE, Tamimi HK, Gray HJ, Peters WA 3rd, Goff BA. Press JZ, et al. Among authors: gray hj. Gynecol Oncol. 2011 Feb;120(2):296-9. doi: 10.1016/j.ygyno.2010.10.019. Gynecol Oncol. 2011. PMID: 21075432

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page